Jishu Li

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

TNF-α blockade for carbamazepine-induced drug reaction with eosinophilia and systemic symptoms.

TNF-α blockade for carbamazepine-induced drug reaction with eosinophilia and systemic symptoms.

Journal: Frontiers in immunology

Published: May 04, 2026

Bullous Pemphigoid: A Focused Review on Antigen Epitopes.

Bullous Pemphigoid: A Focused Review on Antigen Epitopes.

Journal: Experimental dermatology

Published: March 30, 2026

Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study".

Comment on "Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective multicenter cohort study".

Journal: Journal of the American Academy of Dermatology

Published: March 10, 2026

Refractory high-risk mucous membrane pemphigoid treated with telitacicept.

Refractory high-risk mucous membrane pemphigoid treated with telitacicept.

Journal: The British journal of dermatology

Published: January 25, 2026

Immune Checkpoint Inhibitor-Related Bullous Pemphigoid: Distinct Clinical and Immunological Profiles.

Immune Checkpoint Inhibitor-Related Bullous Pemphigoid: Distinct Clinical and Immunological Profiles.

Journal: Experimental dermatology

Published: January 11, 2026

Autoimmune Bullous Diseases Associated With Immune Checkpoint Inhibitors: An Analysis Based on a Systematic Review.

Autoimmune Bullous Diseases Associated With Immune Checkpoint Inhibitors: An Analysis Based on a Systematic Review.

Journal: International journal of dermatology

Published: December 21, 2025

Dupilumab for pruritus associated with dystrophic epidermolysis bullosa: A systematic review.

Dupilumab for pruritus associated with dystrophic epidermolysis bullosa: A systematic review.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 08, 2025

Vedolizumab-induced Bullous Pemphigoid: A Case Report with Serological Evidence and Mechanistic Insights.

Vedolizumab-induced Bullous Pemphigoid: A Case Report with Serological Evidence and Mechanistic Insights.

Journal: Acta dermato-venereologica

Published: October 09, 2025

Dapagliflozin-Associated Bullous Pemphigoid.

Dapagliflozin-Associated Bullous Pemphigoid.

Journal: International journal of dermatology

Published: September 16, 2025

Immune checkpoint inhibitors for patients with autoimmune bullous disease: Insights from a systematic review.

Immune checkpoint inhibitors for patients with autoimmune bullous disease: Insights from a systematic review.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 12, 2025

Autoimmune diseases and malignancies in patients with thymoma: A 9-year retrospective study.

Autoimmune diseases and malignancies in patients with thymoma: A 9-year retrospective study.

Journal: Chinese medical journal

Published: February 26, 2025

Demographic characteristics and disease severity associated with IgA/IgG deposition patterns in autoimmune bullous diseases: a cohort study based on a registry database.

Demographic characteristics and disease severity associated with IgA/IgG deposition patterns in autoimmune bullous diseases: a cohort study based on a registry database.

Journal: Frontiers in immunology

Published: January 22, 2025

Showing 1-12 of 16

Last Updated: 09/26/2026